top of page
Open Site Navigation

Improving personalized prenatal care through maternal microbiome

About Us

MaMome is currently studying how your microbiome can be used to predict and prevent the later development of certain disease conditions, specifically during pregnancy. Our platform leverages precise microbiome sequencing technology for accurate and cost-effective sample testing. 

MaMome’s proprietary algorithms match microbiome data with individual nutritional requirements to improve long-term health care for both mother and child

Clinical Trials registration number 



MaMome strives to broaden the impact of microbiome-based early diagnostics and management of pregnancy complications through its proprietary testing and AI-based nutrition platform. 

Interested in partnering? Contact us at

Established Partnerships:


Complications like preeclampsia, gestational diabetes, and preterm birth cause long-term health effects for both mother and baby and increase your risk for birth interventions. Accurately identifying women at higher risk for pregnancy complications is the first step to preventing pregnancy complications. 


Help us unlock the maternal microbiome by participating in one of our research studies. We provide all participants with no-cost wellness coaching to assist with a healthy diet and other healthy pregnancy behaviors. Studies are completely non-invasive, and you can participate from your own home.

Sign Up For More Information

Scientific & Business Advisors

Nini Fan, MBA MS

Co-founder &

Chief Executive Officer 

Stephanie McClellan, MD

Co-founder &

Chief Medical Officer

Roxana Piotrowska, PhD

Manager of Business Development

Taiwo Togun, PhD

Technology Lead & Computer Vision

Yanjiao Zhao, MD, PhD

Principal Investigator

Xuebin Yin, MD

Principal Investigator




MaMome Inc.
1 University Plaza
Brooklyn, NY 11201


bottom of page